Details of the Drug

General Information of Drug (ID: DMAT7SD)

• Drug Name: AU-011

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1/2	[1]

• Cross-matching ID: TTD ID: D0R0NX

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)